Injecto Polymers IPO

Upcoming SME

Already have an account? Apply now

Injecto Polymers IPO details

11th – 16th Sep 2026
21 Sep 2026
₹98 – ₹100
Lot size 1200 — ₹120000
56cr

Schedule of Injecto Polymers

Issue open date 11 Sep 2026
Issue close date 16 Sep 2026
UPI mandate deadline 16 Sep 2026 (5 PM)
Allotment finalization 17 Sep 2026
Refund initiation 18 Sep 2026
Share credit 18 Sep 2026
Listing date 21 Sep 2026
Mandate end date 01 Oct 2026
Lock-in end date for anchor investors (50%) 16 Oct 2026
Lock-in end date for anchor investors (remaining) 15 Dec 2026

Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.

About Injecto Polymers

Injecto Polymers manufactures and trades plastic packaging products, specializing in high-denier fabrics tailored for heavy-duty applications. The company’s core product portfolio encompasses flexible intermediate bulk containers (FIBC), woven sacks, and bags utilized for packaging fertilizers, cement, food grains, and seeds. Operating out of two manufacturing facilities in West Bengal with a combined installed capacity of 10,870 metric tonnes, the business primarily serves customers in eastern India. Injecto Polymers generates revenue through a combination of manufacturing and trading operations, sourcing raw materials like polypropylene granules, high-density polyethylene, and low-density polyethylene from both domestic and international markets. The company caters to the agriculture, construction, textiles, and chemicals sectors, managing its supply chain through a flexible, order-based sales model designed to adapt to fluctuating customer demand and optimize operational scale.


Financials of Injecto Polymers


Issue size

Funds Raised in the IPO Amount (₹ crores)
Total issue size 56.12
Fresh Issue – Proceeds go to the company 56.12

Utilisation of proceeds

Purpose INR crores (%)
Funding Capital expenditure towards setting up phase IV at Unit-I 30.5 (54.35%)
Repayment and/or prepayment of certain borrowings 10 (17.82%)
General corporate purposes 15.62 (27.83%)

Strengths

  • Phase IV expansion directly scales core manufacturing capacity.
  • Debt repayment will improve overall leverage and financial health.
  • Strong market foothold across the eastern Indian packaging sector.
  • Proven capability to produce heavy-duty, high-denier fabrics.
  • Solar power infrastructure reduces reliance on the state grid.

Risks

  • Phase IV capital expenditure is subject to execution and cost risks.
  • Restrictive debt covenants currently limit our operational flexibility.
  • Top 5 customers generate over 30% of total operating revenue.
  • Heavy reliance on lower-margin trading activities impacts profits.
  • Negative operating cash flows constrain future working capital.